These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 12660508

  • 1. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
    Schütte H, Schell A, Schäfer C, Ghofrani A, Theo Schermuly R, Seeger W, Grimminger F.
    Transplantation; 2003 Mar 27; 75(6):814-21. PubMed ID: 12660508
    [Abstract] [Full Text] [Related]

  • 2. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
    Schermuly RT, Roehl A, Weissmann N, Ghofrani HA, Schudt C, Tenor H, Grimminger F, Seeger W, Walmrath D.
    J Pharmacol Exp Ther; 2000 Feb 27; 292(2):512-20. PubMed ID: 10640287
    [Abstract] [Full Text] [Related]

  • 3. Nebulized phosphodiesterase III inhibitor during warm ischemia attenuates pulmonary ischemia-reperfusion injury.
    Zhang J, Chen F, Zhao X, Aoyama A, Okamoto T, Fujinaga T, Shoji T, Sakai H, Cui Y, Bando T, Date H.
    J Heart Lung Transplant; 2009 Jan 27; 28(1):79-84. PubMed ID: 19134535
    [Abstract] [Full Text] [Related]

  • 4. Reduced ischemia-reperfusion injury with rolipram in rat cadaver lung donors: effect of cyclic adenosine monophosphate.
    Bleiweis MS, Jones DR, Hoffmann SC, Becker RM, Egan TM.
    Ann Thorac Surg; 1999 Jan 27; 67(1):194-9; discussion 199-200. PubMed ID: 10086548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability--effect of adenylate cyclase stimulation and phosphodiesterase inhibition.
    Seeger W, Hansen T, Rössig R, Schmehl T, Schütte H, Krämer HJ, Walmrath D, Weissmann N, Grimminger F, Suttorp N.
    Microvasc Res; 1995 Jul 27; 50(1):1-17. PubMed ID: 7476570
    [Abstract] [Full Text] [Related]

  • 8. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
    Souza DG, Cassali GD, Poole S, Teixeira MM.
    Br J Pharmacol; 2001 Nov 27; 134(5):985-94. PubMed ID: 11682446
    [Abstract] [Full Text] [Related]

  • 9. Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion.
    Schütte H, Löckinger A, Seeger W, Grimminger F.
    Eur Respir J; 2001 Jul 27; 18(1):15-22. PubMed ID: 11510786
    [Abstract] [Full Text] [Related]

  • 10. Maintenance of cAMP in non-heart-beating donor lungs reduces ischemia-reperfusion injury.
    Hoffmann SC, Bleiweis MS, Jones DR, Paik HC, Ciriaco P, Egan TM.
    Am J Respir Crit Care Med; 2001 Jun 27; 163(7):1642-7. PubMed ID: 11401888
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non-heart-beating donors.
    Takashima S, Koukoulis G, Inokawa H, Sevala M, Egan TM.
    J Thorac Cardiovasc Surg; 2006 Jul 27; 132(1):132-9. PubMed ID: 16798313
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model.
    Weiss ES, Champion HC, Williams JA, Baumgartner WA, Shah AS.
    J Thorac Cardiovasc Surg; 2009 May 27; 137(5):1249-57. PubMed ID: 19379999
    [Abstract] [Full Text] [Related]

  • 16. Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor.
    Barnard JW, Seibert AF, Prasad VR, Smart DA, Strada SJ, Taylor AE, Thompson WJ.
    J Appl Physiol (1985); 1994 Aug 27; 77(2):774-81. PubMed ID: 8002527
    [Abstract] [Full Text] [Related]

  • 17. Potential for pulmonary protection by nebulized milrinone during warm ischemia.
    Chen F, Zhang J, Aoyama A, Okamoto T, Fujinaga T, Bando T.
    Transplant Proc; 2008 Dec 27; 40(10):3335-8. PubMed ID: 19100384
    [Abstract] [Full Text] [Related]

  • 18. Pre-arrest administration of the cell-permeable free radical scavenger tempol reduces warm ischemic damage of lung function in non-heart-beating donors.
    Hodyc D, Hnilickova O, Hampl V, Herget J.
    J Heart Lung Transplant; 2008 Aug 27; 27(8):890-7. PubMed ID: 18656803
    [Abstract] [Full Text] [Related]

  • 19. L-arginine inhibits ischemia-reperfusion lung injury in rabbits.
    Yoshida K, Yoshimura K, Haniuda M.
    J Surg Res; 1999 Jul 27; 85(1):9-16. PubMed ID: 10383832
    [Abstract] [Full Text] [Related]

  • 20. Endobronchial donor pre-treatment with ventavis: is a second administration during reperfusion beneficial to optimize post-ischemic function of non-heart beating donor lungs?
    Wittwer T, Franke UF, Sandhaus T, Groetzner J, Strauch JT, Wippermann J, Ochs M, Mühlfeld C, Börner A, Streck S, Wahlers T.
    J Surg Res; 2006 Nov 27; 136(1):136-42. PubMed ID: 16978652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.